**Core Concept**
Succinylcholine is a depolarizing neuromuscular blocker used for rapid sequence intubation and muscle relaxation. It acts by stimulating nicotinic acetylcholine receptors at the neuromuscular junction, leading to muscle depolarization and paralysis. However, its use is contraindicated in certain conditions due to the risk of severe hyperkalemia.

**Why the Correct Answer is Right**
The correct answer is **D. Spinal cord injury above T6**, because patients with spinal cord injuries above T6 have a disrupted sympathetic nervous system, which leads to a reduced risk of succinylcholine-induced hyperkalemia. This is because the sympathetic nervous system is responsible for releasing catecholamines, which can cause a surge in potassium release from muscle cells when succinylcholine is administered.

**Why Each Wrong Option is Incorrect**
**Option A:** Burns - Succinylcholine can cause severe hyperkalemia in patients with extensive burns due to the release of potassium from damaged muscle cells.

**Option B:** Myocardial infarction - Patients with myocardial infarction are at increased risk of succinylcholine-induced hyperkalemia due to the release of potassium from damaged muscle cells.

**Option C:** Muscular dystrophy - Patients with muscular dystrophy are at increased risk of succinylcholine-induced hyperkalemia due to the release of potassium from damaged muscle cells.

**Clinical Pearl / High-Yield Fact**
When administering succinylcholine, it's essential to assess the patient's risk of hyperkalemia, particularly in patients with spinal cord injuries below T6, burns, myocardial infarction, and muscular dystrophy.

**Correct Answer:** D. Spinal cord injury above T6